FDA rejects J&J’s treatment for rheumatoid arthritis
September 25, 2017Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, sirukumab
Perhaps unsurprisingly, after the FDA’s advisory committee had voted 12-1 against approval of Johnson & Johnson’s drug, the FDA returned …
Alnylam soars on likely first RNAi treatment approval
September 22, 2017Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical
Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …
Top Ten most popular articles on Pharmafile.com this week
September 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …
19 deaths from liver drug causes Intercept shares to tumble
September 22, 2017Medical Communications, Sales and Marketing Intercept Pharmaceuticals, Ocliva, biotech, drugs, pharma, pharmaceutical
Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a …
NICE recommends Bayer’s Eylea for myopic chorodial neovascularisation
September 22, 2017Medical Communications, Sales and Marketing Bayer, Eylea, NICE, pharma, pharmaceutical
Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution …
New therapy offers triple threat to HIV virus
September 22, 2017Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …
Weight loss drugs could be used to treat cocaine addiction
September 21, 2017Research and Development addiction, cocaine, cocaine addiction, lorcaserin, pharma, pharmaceutical
Researchers at the Boston Medical Center are investigating the potential of utilising weight loss drugs in the treatment of cocaine …
Witty, Ex-CEO of GSK, keeps busy with two new roles in two days
September 21, 2017Medical Communications : Pharma, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …
Report finds variation in quality of care in GP practices across England
September 21, 2017Medical Communications : Pharma, England, GP, NHS, biotech, drugs, pharma, pharmaceutical
Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …
Merck and Pfizer’s joint skin cancer drug gets EU approval
September 21, 2017Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer
Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …
Bayer pulls plug on sterilisation device after numerous complaints
September 21, 2017Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical
Bayer has stopped the commercial sale of a sterilisation device in all countries, except the US, after reports that it …
Novartis scores EU approval in acute myeloid leukaemia and advanced systemic mastocytosis
September 20, 2017Research and Development, Sales and Marketing EU, Europe, Novartis, acute myeloid leukaemia, advanced systemic mastocytosis, pharma, pharmaceutical
Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in the two rare cancer indications: newly …
Gates Foundation invest in Immunocore, warning of infectious disease threat
September 20, 2017Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, infectious diseases, pharma, pharmaceutical
It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore …
Antibiotic development is inadequate to meet global resistance threat, WHO warns
September 20, 2017Research and Development WHO, antibiotic resistance, antimicrobial resistance, pharma, pharmaceutical, world health organization
The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace …
BMS’ Opdivo to finally be made available to lung cancer patients in the UK
September 20, 2017Research and Development, Sales and Marketing Bristol-Myers Squibb, NICE, biotech, drugs, opdivo, pharma, pharmaceutical
It is two and a half years since patients with lung cancer in the US were able to receive Bristol-Myers …
GSK gets FDA approval for key triple therapy inhaler
September 20, 2017Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical
The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.
Roche and AbbVie’s leukaemia combo smashes Phase 3 endpoint
September 19, 2017Manufacturing and Production, Research and Development AbbVie, Rituxan, Roche, Venclexta, Venclyxto, leukaemia, pharma, pharmaceutical
Venclexta/Venclyxto (venetoclax), Roche and AbbVie’s oral B-cell lymphoma-2 (BCL-2) inhibitor, successfully met its primary endpoint in Phase 3 trials, providing …
Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab
September 19, 2017Manufacturing and Production, Research and Development, Sales and Marketing EMA< CHMP, Janssen, guselkumab, pharma, pharmaceuticals
Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal …
FDA locks down combo immunotherapy trials, Roche added to hold
September 19, 2017Manufacturing and Production, Sales and Marketing Roche, biotech, drugs, immunotherapy, pharma, pharmaceutical, tecentriq
The FDA has moved to ensure that all immunotherapy trials studying PD-1/L1 agents, alongside immunomodulatory medicines in certain blood cancers …
Teva completes sale of women’s health for $1.38 billion
September 19, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical, women's health
Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
